Newsfeeds - Spark Newswire

2 minute read

News

ASLAN Pharma Reports Scientific Collab With Dr. Emma Guttman-Yassky On Identification Of Co.’s ASLAN004-Specific Biomarkers

Today, 6:40 AM

ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced a collaboration with renowned

ASLN

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:40 AM

Gainers

AGMH

2 minute read

Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher

By Lisa Levin

Today, 6:40 AM

Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to 4,453.40.

APOP

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 6:40 AM

APLT

2 minute read

Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide

By Lisa Levin

Today, 6:40 AM

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, gaining 0.02% to 4,456.20.

APOP

3 minute read

31 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 6:40 AM

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission.

APOP

2 minute read

Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August

By Lisa Levin

Today, 6:40 AM

Following the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also fell, dropping 0.22% to 4,445.70.

APOP

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 6:40 AM

ACHL

1 minute read

Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?

By Vandana Singh

Today, 6:40 AM

ASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) has announced topline data from its Phase 1 study of ASLAN004 for moderate-to-severe atopic dermatitis (AD). In…

ASLN